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Abstract
Immunocytochemistry was performed on the cells taken from the ecto/endocervix and endometrium. The monoclonal antibodies 
produced against CD20, CD56 and TLR have been used in the immunocytochemistry. The frequency of the immunocytochemically 
positive cells was estimated before and after a course of sodium nucleospermate treatment, in women suffering from infertility. 
The real–time PCR for HPV of high oncogenic risk was also studied. After the course of the treatment, the frequency of CD20, and 
especially of CD56 positive cells, was found to decrease. The concomitant lowering of the HPV of high oncogenic risk quantity 
was determined by real–time PCR. Otherwise, the frequency of  TLR4 and TLR9 positive cells was found to be elevated. The data 
presented here proved the assumption that sodium nucleospermate actively induces an innate immune response and eliminated factors 
inciting endometrial inflammation.                     
Key words: TLR, CD20, CD56, endometrium, cervix of uteri, sodium nucleospermate.
Introduction
The female reproductive system is a system of cavities 
covered by mucous membranes (in the structure of a particular 
organ), and are interconnected with each other, forming a part of 
the mucosal immune system. Like all other mucous membranes, 
they possess non-specific factors of the immune system, providing 
a  reliable  barrier  against  pathogens,  in  most  cases.  Immune 
protection by the mucous membranes is provided as a result of 
several humoral and cellular factors. There are two populations 
of mucosal membrane cells, which are able to produce antigens. 
These are antigen-presenting cells and cells which implement 
the transport of an unmodified or processed antigen from the 
surface of the epithelial layer. Innate immunity is the first line of 
defense against primary infection and / or recurrent disease. It 
reveals mechanisms that are characterized by very rapid, almost 
immediate reactions. Reactions initiated by the innate immune 
system receptors do not require the proliferation of the T and B 
cell clones, which are necessary for the development of adaptive 
immunity  reactions.  This  explains  the  high  speed  of  innate 
immune responses and their low specificity.
It is well known that in response to a pathogenic invasion, 
an immediate response of the innate immune system in mammals 
is mainly mediated by a family of receptors called TLRs or Toll-
like receptors [1-5], which in German translates as “amazing” 
receptors .These receptors are seen as macrophages, neutrophils, 
natural  killer  cells  and  dendritic  cells.  They  recognize  the 
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highly conserved model molecules typical for the entire group 
of microorganisms, the so-called PAMP (pathogen-associated 
microbial  patterns). An  example  of  such  structures  could  be 
components  of  the  bacterial  walls,  lipopolysaccharides  of 
Gram-negative bacteria, peptidoglycans and lipoteichoic acids 
of Gram-positive bacteria, flagellin, and viral nucleic acids.
To date, 11 types of this receptor family have been cloned. 
At the same time, different types of receptors predominantly 
connect with different ligands (antigens). However, despite a 
great variety of receptors in this family, the 1, 2, 4, 5 and 6 types 
of TLRs were found to bind preferentially to bacterial antigens, 
whereas the 3, 7, 8 and 9 types of TLRs were noted to preferably 
bind to the RNA and / or DNA nucleotide sequences. Clinical 
observations  indicate  that  a  variety  of  viruses  including  the 
herpes simplex virus, human papilloma virus, hepatitis B and 
C, Cytomegalavirus, human immunodeficiency virus, etc. can 
infect the female genital tract. In light of this, the special role of 
the receptors is supported by data which reveals the mechanism 
of  the  triggering  of  an  immediate  immune  system  response 
mediated by the Toll-like receptors 3, 7, 8 and 9 types to viral 
infection. Thus, for example, it is assumed, that TLR3 recognizes 
the double-stranded RNA. However, it should be noted, that the 
double-stranded RNA(dc-RNA)  can arise from various sources. 
However, even samples of single-stranded RNA viruses often 
contain  defective  particles  that  primarily  contain  defective 
primary  double-stranded  genomes.  Intracellular  viral  double-
stranded RNA (dc-RNA)   may be generated in different ways. In 
the case of single-stranded viruses, the formation of intermediate 
products of replication like dc-RNA is an obligatory stage in 
viral  production.  Whereas,  in  the  case  of  DNA  viruses,  the 
complementary matrix RNA is often produced in such a manner 
that it is synthesized by the partially overlapping genes, located 
on the opposite chains of the viral genome (double-stranded). 
Long viral polycistronic matrix RNA often contains extra stable 
double-stranded “stems”. These observations indicate that all 
viral infections pass through the stage of double-stranded RNA 
at the time of viral genome replication. Recently, it was shown 
that the matrix RNA arising from the dying or dead cells of the 
host organism activates TLR3, suggesting that the activation of 
the innate immune response via TLRs may occur under various 
conditions. It has also been convincingly demonstrated that the 
secondary structure forming a loop as a “stem” in the matrix 
RNA is responsible for the TLR activation, where the nucleic 
acids are the ligands.
It  was  found  that,  for  instance,  that  TLR3  detects  the 
double-stranded nucleic acid from Schistosoma mansoni and 
is very involved in the immune response against parasites. To 
date, it has been generally found that the DNA and RNA from 
different sources may trigger an immediate immune response 
through certain types of Toll-like receptors.
Moreover, the TLRs may represent a target for the so-
called targeted therapies. The human papilloma virus, during 
its  evolution  has  acquired  the  ability  to  “escape”  from  the 
immunological protection of the human immune system. It is 
shown that HPV 16 inhibits the expression of the 9th type of TLR 
in the epitheliocytes and dentritic cells. As a result, therapeutic 
vaccines are produced with adjuvants that can activate the Toll-
like receptors expressed on the surface of the dentritic cells. 
In light of this, it is of great interest to study the drugs that 
interact  with  the TLR.  However,  various  immunomodulators 
act as TLR modulators. Thus, the degree of TLR expression in 
the multi-planar and cylindrical epithelium of the cervical and 
endometrial tissue in bacterial and viral infections before and 
after the treatment assumes great significance.
Material and Methods
The material taken from the surfaces of the ectocervix 
and endocervix and the aspirate from the uterine cavity were 
deposited on a glass slide and immediately subjected to wet 
fixation using fixative «BioFix».
The drugs thus fixed were stored in a dry, dark place for 
several weeks before starting the immunocytochemical reaction. 
Prior  to  beginning  the  immunocytochemical  reaction,  the 
products were incubated in 50% ethanol for 10 min to remove 
the fixator. Then, they were washed twice with distilled water 
and placed in a citrate buffer (pH 6.0) (Diagnostic BioSystem, 
K  035),  in  which  the  desired  antigen  unmasking  was  later 
performed.
To accomplish this, a pressure cooker was filled with the 
citrate buffer and, on reaching boiling point, the drugs were 
placed in it. Antigen unmasking was thus performed in 40-45 
min. At  the  end  of  the  unmasking,  the  pressure  cooker  was 
cooled, and after the buffer cooled down, the products were 
removed. To prevent drying, excess moisture was removed using 
a filter paper, and the immunocytochemical field was localized 
with a hydrophobic pen (Elite PAP Pen (Diagnostic BioSystem, 
K 039)). 
Excessive  quantities  of  endogenous  peroxidase  were 
blocked for 10 min using a commercial composition «Peroxidase 
Block», which is a set of the «PolyVue HRP / DAB Detection 
System» (Diagnostic BioSystem). After incubation, the products 
were carried out in the washout buffer and  the first antibody 
in  the  following  format  were  applied:    for  cell  verification, 
to  express  the  CD20  and  NCAM/CD56  antigens,  mouse 
monoclonal antibodies (Ab) - mouse monoclonal anti B cell, 
CD20 (clone L26) and mouse monoclonal anti CD56 (clone 
123C3.D5), respectively, were used. 
Both  the  products  were  obtained  from  «Diagnostic 
BioSystem». For cell verification, to express the TLR4  and 
TLR9, mouse monoclonal antibodies to human antigens - a clone 
of a clone and 76V357.1 26S593.2, respectively, were used. 
Both  products  were  obtained  from  «Lifespan,  Biosciences». 
Dilutions of all the first antibodies were optimized individually. 
Incubation of the products with the first antibody was conducted 
in a moist chamber at 37°C for half an hour.
By the end of the incubation, the products were washed 
three  times  using  the  washout  buffer.  Then  the  «Polymer 
Penetration Enhancer» reagent was applied for 10 min (at room 
temperature), which was later washed off in the buffer.
For the next stage of the immunocytochemical reaction, 
a polymer system was used, directed against the first antibodies 
(Anti-Mouse/Rabbit PolyVue HRP Label from a set «PolyVue 
HRP / DAB Detection System»). Products were incubated for 
an  hour  at  room  temperature. After  washing  the  incubation 
products,  they  were  visualized  within  the  optimum  time 
period for the product of immunocytochemical reaction, using 
chromogen - diaminobenzidine (DAB / plus chromogen). Next, 
the products were washed thoroughly to remove traces of the 
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using hematoxylin (hematoxylin Karratsi).
Bearing  in  mind,  that  the  drugs  obtained  from  the 
endometrium and lower genital tract represent cellular material, 
it is useful to evaluate CD20-and CD56-positive cells, as well 
as the cells expressing TLR, irrespective of how many of them 
were found in one field of view or another, and to evaluate the 
frequency of their occurrence in terms of percentage. It should 
be noted, that the «Histoscore system» is also unacceptable in 
this study, as it is based on a study of histological preparations, 
whereas  in  the  present  study  we  investigated  only  cellular 
material. 
Documentation of the immunocytochemical studies was 
performed using an MD125 Leica microscope (Germany) in the 
laboratory of functional morphology of the central and peripheral 
nervous systems (lab supervisor, Korzhevsky, MD, DM) in the 
Institute of Experimental Medicine, RAMS (St. Petersburg).
To estimate the viral load of HPV (human papilloma virus), 
taken  from  patients  before  and  after  sodium  nucleospermate 
(POLYDAN, Russia) treatment, the “polymerase chain reaction 
in real time» method, generally accepted in practice across the     
world, was employed.
Results
As  shown  by  the  results  obtained,  the  cells  reacting 
positively to the desired antigens, were stained brown due to 
the reaction of horseradish peroxidase, which is associated, in 
the imaging system, with diaminobenzidine chromogen (Fig.1).
Signal distribution (color) in the cells is usually uneven. 
For  example,  it  is  clear,  that  the  cytoplasm  compared  with 
the region “above the core” has a more intense brown color. 
Antigens CD20 and CD56 are glycoproteins expressed on the 
B-and NK-cell plasma membranes, respectively. In some cases, 
the cytoplasmic portion “above the core” also gets intensely 
stained (Fig.2).
To identify the reasons for the variation in the staining 
intensity  with  the  monoclonal  antibodies  of  the  cytological 
object,  we  referred  to  the  following  scheme.  In  Figs.  3  and 
4, a formalized scheme of spatial staining of the cells in the 
cytological preparations is given, i.e., an immunocytochemical 
study which is fundamentally different from the spatial staining 
of the histological preparations (immunohistochemical study). 
Based on the spatial location of an object, it is obvious, that in 
the cytological preparations the plasma membrane, which is not 
addressed on the glass slide, can fully “present” all the required 
antigens on its surface, for binding with these monoclonal Ab.
Whereas,  for  the  object  (cell)  in  the  histological 
preparation  the  intensity  of  tagging  depends  on  how  “many 
times” the plasma membrane is “cut off” (or “left”) as a result of 
the histological processing unit. 
The frequency of the cells in the endometrium expressing 
the CD20 and the CD56 antigen varies significantly, which is 
due, apparently, to the varying rates of inflammation (Figs. 5 
and 6, respectively). It should be noted, that in the cytological 
preparations, often, cells may be artificially divided; however, it 
does not diminish the value of the immunocytochemical study 
of the mucosal endometrium.
Assessment  of  the  frequency  of  the  cells  expressing 
the desired antigen is more accurate when compared with the 
mechanical extrapolation of the histological approach, which is 
reflected in the results presented on the system “in the field of 
view.”
In the last case, it could lead to an “overestimation” of the 
results of the research on the cells expressing the desired antigen. 
As seen from Fig. 7 (The scheme of immunocytochemical study; 
Figure 1
 Aspirate from the uterine cavity of 
patient with chronic endometritis:   
CD20+. Immunocytochemistry. 
Hematoxylin ×1000
Figure 2
Aspirate from the uterine cavity of 
patient with chronic endometritis:   
CD20+. Immunocytochemistry. 
Hematoxylin ×1000
Figure 3
The scheme of histological 
slide  in  paraffin  block  (a), 
after preparation with 
microtome (b) followed by 
immunohistochemistry  with  
monoclonal antibodies (c)      
Figure 4
The scheme of smear (liquid 
cytology) which spread on the 
surface of microscope slide (a) 
followed by immunocytochemistry 
with monoclonal antibodies (b)  
Figure 5
 Aspirate from the uterine cavity of 
patient with chronic endometritis:  
CD20+. Immunocytochemistry. 
Hematoxylin ×1000
Figure 6
 Aspirate from the uterine cavity of 
patient with chronic endometritis.   
CD56+. Immunocytochemistry. 
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the cells of gray color are elaborated by immunocytohemistry), 
if the result is shown in the system “in sight”, it can be concluded 
that there is a high degree of infiltration of the endometrium by 
cells expressing this antigen in the field, as shown in Fig. 7a.
Therefore, it can be concluded, that in this field of view 
there are six cells positively labeled by the monoclonal antibodies, 
compared with the material 
of  the  endometrium,  as 
shown  in  Fig.  7b,  (only 
three cells with a positive 
signal  are  observed  in 
the  immunocytochemical 
reaction in the conditional). 
However,  if  we 
estimate  the  frequency  of 
the  positive-labeled  cells 
in all the cell populations 
represented in these fields 
of view, we find that in the 
field of view in Fig. 7a, the 
frequency of the positive-
labeled  cells  is  not  more 
than 26%, while in the field 
of view shown in Fig. 7b, 
the  frequency  of  positive 
cells  in  the  conventional 
immunocytochemical reac-
tion is not less than 33%. 
As seen from Fig. 8, on documenting the immunocyto-
chemical  study  of  material  from  the  endometrium  using 
monoclonal antibodies to the antigen CD 56, the NK - cells can 
form clusters that appear to indicate a high degree of infiltration 
of  the  endometrium  in  chronic  endometritis. After  treatment 
with  sodium  nucleospermate  mucosal  the  infiltration  of  the 
endometrial  cells,  expressing  the  CD56  antigen  decreased 
(Fig.9). However, it should be noted, to achieve a more accurate 
estimation of the frequency of the positive-labeled cells with 
monoclonal  antibodies  it  is  necessary  to  study  the  largest 
possible number of fields of view (and a larger amount of cells), 
because during inflammation, the material received from the 
endometrium often contains mucus and depleted cell material 
(Fig.10). Immunocytochemistry of the cells expressing TLR4 
and TLR9 elucidated the following difference. The both types of 
TLRs were detected with low frequency (less than 1 %)  in the 
smears taken from the ectocervix of patients with a high HPV 
viral load (Fig.11). The cells expressing TLR4 were as high as 
10% in the endocervix of the same patients. The endometrium 
of patients without chronic endometritis has been documented 
for high frequency of cells expressing TLR4 (>50 %) (Fig.12). 
As  seen  from  Fig.  13,  showing  the  documentation  of 
the immunocytochemical study of the cells expressing TLR9, 
the signal is diffusely distributed into the cells. As is known, 
the nucleic acids are ligands for TLR9 which express onto the 
internal membranes of the cell endosomes [1-7]. Consequently, 
the  monoclonal  antibodies  for  TLR9  penetrate  the  plasma 
membrane. In the next step, they enter into the cell and then bind 
to the TLR expressing onto the internal side of the endosomal 
membrane (Fig.14). 
Figure 7
Figure 8
Aspirate from the uterine cavity of 
patient with chronic endometritis:  
CD56+. Immunocytochemistry. 
Hematoxylin ×1000
Figure 9
 Aspirate from the uterine cavity of 
patient with chronic endometritis:  
CD56+. Immunocytochemistry. 
Hematoxylin ×1000
Figure 10
Aspirate from the uterine cavity of 
patient with chronic endometritis:  
CD56+. Immunocytochemistry. 
Hematoxylin ×1000
Figure 11
Ectocervix of patient with chronic 
endometritis(cytological smear): 
TLR4+.  Immunocytochemistry.  
Hematoxylin ×1000
Figure 12
Aspirate from the uterine cavity of 
patient with chronic endometritis:  
TLR4+. Immunocytochemistry. 
Hematoxylin ×1000
Figure 13
 Aspirate from the uterine cavity of 
patient with chronic endometritis.   
TLR9+. Immunocytochemistry. 
Hematoxylin ×1000
Figure 14
The scheme of immuno-
cytochemistry with mono-
clonal antibodies raised 
against TLR9 localized in 
internal membrane of cell 
endosomes       265                                       S. N. Proshin et al. / International Journal of BioMedicine 2(4) (2012) 261-266
Discussion 
In the preliminary studies, it was found that the Toll-like 
receptors are one of the key components of innate immunity. 
The fact that, thus far, at least 11 types of TLR in mammals have 
been cloned emphasizes the evolutionary significance of this 
receptor type in the body’s defense (in its internal environment) 
against a variety of pathogens. The expression of certain types 
of TLRs in the lower and upper parts of the female reproductive 
tract, however, was quite different.
Therefore, with a high degree of reliability, it was found, 
that the regular expression of TLR (both the 1 and 6 types), 
was registered in the epithelium lining of both the upper and 
lower  portions  of  the  reproductive  tract:  the  fallopian  tubes, 
endometrium, endo- and ectocervix and the vagina, regardless 
of the phase of the cycle [3, 17-19].
It was interesting to note that the expression of TLR1  was 
registered on the NK-cells and endothelial cells of the uterus, 
as well as in the smooth muscle cells of this organ, whereas the 
expression of TLR6 was revealed not only, for instance, on the 
NK-cells infiltrating the stroma of the uterus, but in the vagina 
as well, in the submucosal fibroblasts [18].
A regular expression of the TLR2  was detected in the 
mucosal and stromal cells, in all sections of the reproductive 
tract. At the same time, in the endometrial stromal cells, the 
TLR2 expression was higher when compared with the cells of 
the single-layer columnar epithelium. Peak expression of TLR2 
was registered during the secretory phase of the menstrual cycle 
[19-21].
One of the key types of the TLR in the defense against 
microorganisms  is  undoubtedly  the  Toll-like  receptor  type 
4. The ligand for TLR4 is lipid A or an endotoxin, which is 
linked  with  the  oligosaccharide  chain  and  O-antigen.  These 
components together represent a lipopolysaccharide, which is 
an integral part of the cell wall of gram-negative bacteria (e.g., 
Helicobacter pylori).
In addition, the well-documented ligands for TLR4 also 
include the Heat-shock proteins with a molecular mass of 60 Da, 
glycosphingolipids of protozoa and a number of proteins of viral 
capsids. But most importantly, the binding of Toll-like receptor   
type 4 with molecules MD-2 and CD14 leads to the mobilization 
of factor MyD88.
This,  in  turn,  leads  to  the  phosphorylation  of  the 
kinase  associated  with  the  receptor  for  interleukin  1  type, 
oligomerization  of  factor  6  associated  with  the  receptor  for 
TNF and degradation of the molecule IkB, following after this 
molecular cascade [22-23].
At  the  cellular  and  tissue  level,  binding  of  the  TLR4 
with  the  MD-2  and  CD14  molecules  leads  to  the  activation 
of the transcription genes encoding the various antiphlogistic 
cytokines, chemokines and their associated factors, which are 
also necessary for the further development of immune response.
In  the  context  of  the  clinical  data,  it  must  be  stated, 
that with regard to the microorganisms, the ligands for TLR4 
is LPS of N. gonorrhoeae, LPS and heat-shock protein of the 
C.  trachomatis  microorganism  and  the  carbohydrate  mannan 
of the C. albicans microorganism [24-27]. It is, therefore, not 
surprising, that the TLR4, as a receptor, for which the ligands are 
clinically relevant factors, is expressed by the cells lining both 
the lower and upper portions of the reproductive tract.
In our study, the expression of TLR4 by the cells lining the 
endo- and ectocervix was recorded (see results). Also, we found, 
that in the material taken from the endocervix, the frequency of 
cells expressing TLR4 was higher than that in the epithelium 
of  the  mucous  membranes  of  the  ectocervix.  However,  the 
highest frequency of cells expressing TLR4 was found in the 
endometrium. It should be noted that the frequency of cells lining 
the endometrium were positive in their immunocytochemical 
reaction  for  TLR4,  although  they  varied  widely  in  different 
patients.
Patients were identified having a frequency of at least 80% 
of cells expressing TLR4 in the endometrial lining; patients with 
a frequency of less than 15% of cells expressing TLR4 in the 
endometrial lining were also revealed.
Indeed, several authors, although this is not true of all the 
researchers, discovered, that the “gradient” of the expression of 
TLR4 is higher in the cells lining the upper reproductive tract 
and are at their lowest in the cells lining the vaginal and stromal 
elements [20].
However,  there  is  some  controversy  regarding  the 
localization of the cells showing TLR4 expression; however, 
the  intensity  of  expression  of  TLR4  may  be  related  to  the 
phase of the menstrual cycle when the material taken from the 
reproductive tract was studied. To date, very strong evidence has 
been received confirming that the most pronounced expression of 
the TLR4 in the endometrium is registered during the secretory 
phase of the menstrual cycle [19,28]. 
Our data strongly suggest that, as a rule, in the material 
of  the  ectocervix  in  patients  with  persistent  HPV  infection, 
cells expressing TLR9 were totally absent. In rare cases (10%), 
in the material of the ectocervix, cells expressing TLR9 were 
recorded. If, prior to treatment, the frequency of the cells in 
the  endometrium  expressing TLR9  did  not  exceed  3%,  then 
post treatment with sodium nucleospermate the frequency of 
the  positive  cells  in  the  immunocytochemical  reaction  with 
monoclonal antibodies for Toll-like receptor type 9 increased 
and accounted for more than 10% (i.e., more than three times).
It  is  known  that  the  TLR9  binds  to  the  nucleic  acids 
containing CpG-islands (not subjected to methylation) [8,29], 
which are also found in the genome of the herpes simplex virus 
[30].  Expression  of TLR9  was  registered  in  the  cells  of  the 
fallopian tubes, endometrium and cervix. It should be noted that 
the expression of the TLR9 in the endometrium is not limited to 
the epithelial cells, but is also recorded in the stromal elements 
[21].
The  result  of  the  activation  of  the  TLR9  may  be  an 
increase in the number of cytokines, including IL-8, which the 
experimental data strongly suggest. Thus, the unmethylated CpG 
oligonucleotides, which are the agonists of Toll-like receptor 
type 9, induce the production of the IL-8 by the primary cells, 
isolated from the tissues of the fallopian tubes and cervix [6].
In light of this observation, it is interesting to notice, that 
the  CpG  oligonucleotides  also  inhibit  the  persistence  of  the 
cytomegalovirus and Epstein-Barr virus in the epithelium of the 
vaginal mucosa. One of the cytokines that inhibits the production 
of these pathogenic viruses is IFN - beta. The significance of the 
contamination of the human reproductive system by the Epstein-
Barr virus as inflammation and the inability to conceive has not 
yet been studied and a full research is warranted with regard to 
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immune response. Our data strongly suggest the possibility of 
a correction of the expression of the TLR cells by the female 
reproductive system, with the use of sodium nucleospermate.
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